accepted and acknowledged
on 17 Oct 2022
Last Applicant/ Owned by
21 Holborn Viaduct
London
GB
EC1A2DY
Serial Number
86943755 filed on 17th Mar 2016
Registration Number
5179368 registered on 11th Apr 2017
Correspondent Address
Michael N. Mercanti
Filing Basis
1. intent to use
Disclaimer
"BIOSCIENCES"
In the statement, line 1, "Sigma-Tau Rare Disease Limited" should be deleted and "Leadiant Biosciences Limited" should be inserted. Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders,Read More
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders, inflammatory disorders, cancer and rare diseases, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in gastroenterological areas and the prevention and treatment of ocular disorders or diseases; dietary supplements for humans and animals
No 86943755
No Service/Collective Mark
No 317-21081005
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 17th Oct 2022 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 12th Oct 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 14th Apr 2022 | TEAS SECTION 8 & 15 RECEIVED |
| 11th Apr 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 28th Feb 2018 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 18th Sep 2017 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 11th Sep 2017 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| 01st Aug 2017 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 17th Jul 2017 | OTQR WITHDRAWAL FROM PUBLICATION |
| 06th Jul 2017 | POST REGISTRATION ACTION CORRECTION |
